Skip to content
AnalystLens
Back to BBIOIncome Statement

BridgeBio Pharma Gross Profit 2020-2026 | BBIO

Annual FY2021–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$481.1M

+120.7%YoY vs FY2024Source: 10-KFY2025

From $66.6M in FY2021 to $481.1M in FY2025: 7.2× in 4 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$185M+61.9%$229M+113.8%$333M+191.5%Not reported
FY25$114M−45.9%$107M+6709.7%$114M+5248.5%$146M+3746.0%
FY24$211M+17816.8%$2M+50.7%$2M−38.9%$4M+231.1%
FY23$1M$1M−98.6%$3M+971.1%$1M
FY22Not reported$73M+35.5%−$401K−145.1%Not reported
Share46%13%25%16%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+63.9%

FY2021
$66.6M
FY2025
$481.1M

4 years selected · on the chart

Gross Profit History

Year-over-year comparison from 10-K annual reports

  1. $481.1M
YoY changeLargest recent move−90.8%in FY23Latest +120.7%

1 older move runs past ±150% (largest +3079.6%); point at, tap or drag across the bars to read one.

Gross Profit, period by period

PeriodValueChangeSource
FY2025$481.1M+120.7%10-K
FY2024$218.0M+3079.6%10-K
FY2023$6.9M−90.8%10-K
FY2022$74.2M+11.4%10-K
FY2021$66.6M—10-K

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is BridgeBio Pharma's current gross profit?

BridgeBio Pharma (BBIO) annual gross profit for 2025 was $481.1M, a 120.67% increase from 2024. BridgeBio Pharma gross profit for the quarter ending September 30, 2026 was $332.7M.

What was BridgeBio Pharma's gross profit in 2024?

BridgeBio Pharma annual gross profit for 2024 was $218.0M, a 3079.58% increase from 2023.

What was BridgeBio Pharma's gross profit in 2023?

BridgeBio Pharma annual gross profit for 2023 was $6.9M, a 90.76% decline from 2022.

What is BridgeBio Pharma's 4-year gross profit CAGR?

BridgeBio Pharma gross profit grew at a compound annual growth rate (CAGR) of 63.94% from FY2021 to FY2025, going from $66.6M to $481.1M over 4 years.

Company
BridgeBio Pharma
Ticker
BBIO
Sector
Healthcare
Industry
Pharmaceutical Preparations